Literature DB >> 9403048

Can positron emission tomography distinguish tumor recurrence from irradiation sequelae in patients treated for larynx cancer?

K M Greven1, D W Williams, J W Keyes, W F McGuirt, N E Watson, L D Case.   

Abstract

PURPOSE: Distinguishing persistent or recurrent tumor from post-radiation edema or soft-tissue/cartilage necrosis in patients treated for carcinoma of the larynx can be difficult. Because recurrent tumor is often submucosal, multiple deep biopsies may be necessary before a diagnosis can be established. Positron emission tomography with F-18 fluorodeoxyglucose was studied for its ability to aid in this problem. PATIENTS AND METHODS: FDG PET scans were performed on 31 patients who were suspected of having persistent or recurrent tumor after radiation treatment for carcinoma of the larynx. Patients underwent thorough history and physical examinations, scans with computed tomography (23 patients), and pathological evaluation when indicated. PET scans were interpreted by each of the two radiologists, who were blinded to patient outcome and the other's report.
RESULTS: The time between completion of radiation treatment and positron emission tomography examination ranged from 2 to 61 months with a median of 6 months. Fifteen patients had pathological evidence of tumor in the larynx, while 16 have remained without evidence of disease. The overall sensitivity and specificity of the positron emission tomography interpretations were 80% and 81%, respectively. The sensitivity and specificity of the computed tomography scan interpretations were 58% and 100%, respectively. Of the 23 patients with computed tomography scans, eight patients acquired useful information from the positron emission tomography, three patients had incorrect positron emission tomography interpretations and correct computed tomography interpretations, and one patient had positive tumor despite a negative positron emission tomography and computed tomography. DISCUSSION: Positron emission tomography is useful in distinguishing benign from malignant changes in the larynx after radiation treatment. This noninvasive technique can supplement information provided by computed tomography scans. It is reasonable to delay biopsy, which could traumatize radiation-damaged tissues and precipitate necrosis, for those patients with negative positron emission tomography scans who have clinical signs and symptoms associated with recurrence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9403048

Source DB:  PubMed          Journal:  Cancer J Sci Am        ISSN: 1081-4442


  6 in total

1.  Diagnosis of recurrent uterine cervical cancer: computed tomography versus positron emission tomography.

Authors:  D H Park; K H Kim; S Y Park; B H Lee; C W Choi; S Y Chin
Journal:  Korean J Radiol       Date:  2000 Jan-Mar       Impact factor: 3.500

Review 2.  Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers.

Authors:  Hubert Vermeersch; David Loose; Hamphrey Ham; Andreas Otte; Christophe Van de Wiele
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-10-22       Impact factor: 9.236

Review 3.  The impact of functional imaging on radiation medicine.

Authors:  Nidhi Sharma; Donald Neumann; Roger Macklis
Journal:  Radiat Oncol       Date:  2008-09-15       Impact factor: 3.481

4.  Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy?

Authors:  Jan Wedman; Jan Pruim; Lisa van der Putten; Otto S Hoekstra; Remco de Bree; Boukje A C van Dijk; Bernard F A M van der Laan
Journal:  Clin Otolaryngol       Date:  2018-11-18       Impact factor: 2.597

5.  The cost-effectiveness of 18FDG-PET in selecting patients with suspicion of recurrent laryngeal carcinoma after radiotherapy for direct laryngoscopy.

Authors:  Addy C G van Hooren; Jolijn Brouwer; Remco de Bree; Otto S Hoekstra; C René Leemans; Carin A Uyl-de Groot
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-29       Impact factor: 2.503

6.  2-Deoxy-2[F-18]FDG-PET for detection of recurrent laryngeal carcinoma after radiotherapy: interobserver variability in reporting.

Authors:  L van der Putten; O S Hoekstra; R de Bree; D J Kuik; E F I Comans; J A Langendijk; C R Leemans
Journal:  Mol Imaging Biol       Date:  2008-07-12       Impact factor: 3.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.